Stem cells for reprogramming: could hUMSCs be a better choice?

被引：11
|
作者：
Duya, Paulina [1 ]
Bian, Yuhong [1 ]
Chu, Xiaoqian [1 ]
Zhang, Yanjun [1 ]
机构：
[1] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China
来源：
CYTOTECHNOLOGY | 2013年 / 65卷 / 03期
基金：
中国国家自然科学基金;
关键词：
Human umbilical cord mesenchymal stem cells; Embryonic stem cells; Pluripotency; Reprogramming; HUMAN UMBILICAL-CORD; MESENCHYMAL PROGENITOR CELLS; BONE-MARROW; AUTOIMMUNE-DISEASE; STROMAL CELLS; SELF-RENEWAL; IN-VITRO; BLOOD; DIFFERENTIATION; TRANSPLANTATION;
D O I：
10.1007/s10616-012-9489-3
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Human umbilical cord mesenchymal stem cells (hUMSC) are primitive multipotent cells capable of differentiating into cells of different lineages. They can be an alternative source of pluripotent cells since they are ethically and regulatory approved, are easily obtained and have low immunogenicity compared to embryonic stem cells which are dogged with numerous controversies. hUMSC can be a great source for cell and transplantation therapy.
引用
收藏
页码：335 / 345
页数：11
相关论文
共 50 条
  • [31] Reprogramming to developmental plasticity in cancer stem cells
    O'Brien-Ball, Caitlin
    Biddle, Adrian
    DEVELOPMENTAL BIOLOGY, 2017, 430 (02) : 266 - 274
  • [32] Stem Cells Reprogramming in Diabetes Mellitus and Diabetic Complications: Recent Advances
    Madkor, Hafez R.
    Abd El-Aziz, Mostafa K.
    Abd El-Maksoud, Mostafa S.
    Ibrahim, Islam M.
    Ali, Fares E. M.
    CURRENT DIABETES REVIEWS, 2025, 21 (04) : 21 - 37
  • [33] Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture
    Cheng, LZ
    Hammond, H
    Ye, ZH
    Zhan, XC
    Dravid, G
    STEM CELLS, 2003, 21 (02) : 131 - 142
  • [34] Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells
    Patel, Minal
    Yang, Shuying
    STEM CELL REVIEWS AND REPORTS, 2010, 6 (03) : 367 - 380
  • [35] Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture
    Drela, Katarzyna
    Lech, Wioletta
    Figiel-Dabrowska, Anna
    Zychowicz, Marzena
    Mikula, Michal
    Sarnowska, Anna
    Domanska-Janik, Krystyna
    CYTOTHERAPY, 2016, 18 (04) : 497 - 509
  • [36] Cardiomyocyte differentiation of perinatally-derived mesenchymal stem cells
    Nartprayut, Kuneerat
    U-Pratya, Yaowalak
    Kheolamai, Pakpoom
    Manochantr, Sirikul
    Chayosumrit, Methichit
    Issaragrisil, Surapol
    Supokawej, Aungkura
    MOLECULAR MEDICINE REPORTS, 2013, 7 (05) : 1465 - 1469
  • [37] Nuclear reprogramming and pluripotency of embryonic cells: Application to the isolation of embryonic stem cells in farm animals
    Renard, J.-P.
    Maruotti, J.
    Jouneau, A.
    Vignon, X.
    THERIOGENOLOGY, 2007, 68 : S196 - S205
  • [38] A Medium-Throughput Analysis of Signaling Pathways Involved in Early Stages of Stem Cell Reprogramming
    Fritz, Ashley L.
    Mao, Sunnie R.
    West, Mary G.
    Schaffer, David V.
    BIOTECHNOLOGY AND BIOENGINEERING, 2015, 112 (01) : 209 - 219
  • [39] Immunogenicity of insulin-producing cells derived from human umbilical cord mesenchymal stem cells
    Yang, Xiao-Fei
    Chen, Tao
    Ren, Li-Wei
    Yang, Lu
    Qi, Hui
    Li, Fu-Rong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (04) : 1456 - 1464
  • [40] TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells
    Secardin, Lise
    Gomez Limia, Cintia Elisabeth
    di Stefano, Antonio
    Bonamino, Martin Hernan
    Saliba, Joseph
    Kataoka, Keisuke
    Rehen, Stevens K.
    Raslova, Hana
    Marty, Caroline
    Ogawa, Seishi
    Vainchenker, William
    Reis Monte-Mor, Barbara da Costa
    Plo, Isabelle
    STEM CELL RESEARCH, 2020, 44
12345